Professor and co-Director of the "Extracellular Matrix, Cancer and Therapeutic Targets" team at MEDyC laboratory (UMR CNRS 7369, Reims, France). My research focuses on deciphering the cell-extracellular matrix interplays within the tumor microenvironment, with the aim of identifying new therapeutic targets and designing peptide-based therapeutic strategies. Extensive skills and expertise in cancer research and therapeutic targeting. Co-founder of Apmonia Therapeutics, a biotechnology company dedicated to the development of anti-cancer strategies. I operate within the company as scientific counsel and Chair of the Scientific and Clinical Advisory Board.